Višňanský Martin, Pharm.D., PhD, MBA, MSc.
Research/art/teacher profile
Date of last update: 11.06.2025
I. Basic information
| I.1 Surname |
Višňanský |
|---|---|
| I.2 Given name |
Martin |
| I.3 Degrees |
Pharm.D., PhD, MBA, MSc. |
| I.4 Year of birth |
1970 |
| I.5 Name of the workplace |
University of Veterinary Medicine and Pharmacy in Košice, Department of Pharmacy and Social Pharmacy |
| I.6 Address of the workplace |
Komenského 73, 041 81 Košice, Slovak Republic |
| I.7 Position |
lecturer |
| I.8 E-mail address | martin.visnansky@uvlf.sk |
| I.9 University staff register / partner university profile | https://www.portalvs.sk/regzam/detail/21878 |
| I.11 ORCID iD | 0009-0000-7319-9688 |
II. Higher education and further qualification growth
| Institution | Year | Study field and programme | |
|---|---|---|---|
| Second degree higher education | Comenius University in Bratislava | 1993 | clinical pharmacy |
| Third degree higher education | Comenius University in Bratislava | 2007 | corporate management |
III. Current and previous employment
| Occupation | Institution | Year |
|---|---|---|
assistant - lecturer | University of veterinary medicine and pharmacy in Kosice | 2013 – to date |
Board Member and Director of Strategy and Drug Policy Department | General Health Insurance, join-stock company, Bratislava | 2008 – 2010 |
Chairman of the Board and Managing Director | Svet zdravia, join-stock company, Bratislava | 2005 – 2007 |
Managing Director | Boehringer - Ingelheim Pharma, Ltd., Bratislava | 2002 – 2004 |
IV. Development of pedagogical, professional, language, digital and other skills
| Activity | Institution | Year |
|---|---|---|
Strategic Management and Financial Management for Pharma Industry | SDA Bocconi University, Milan, Italy | 2013 |
Master of Science in Health Technology Assessment and Health Management | Università Cattolica del Sacro Cuore, Roma, Italy | 2011 |
Master of Business Administration | Katz Graduate School of Business, University of Pittsburgh, PA, USA | 2000 |
V. Overview of activities within the teaching career at the university
Academic year: 2026/2027
V.1. Overview of taught profile courses
No records yet.
V.2. Responsibility for the delivery, development and quality assurance of study programmes
No records yet.
V.3. Responsibility for the development and quality of habilitation and inauguration fields
No records yet.
V.4. Overview of supervised theses
| Bachelor | Master | Doctoral | |
|---|---|---|---|
| Currently supervised theses | 0 | 3 | 0 |
| Defended theses | 0 | 48 | 0 |
V.5. Overview of other taught courses
| Course | Study programme | Degree | Study field |
|---|---|---|---|
Economics and management for of pharmacists | Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language | I. + II. | Pharmacy |
Pharmaceutical economics and management for pharmacists | Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language | I. + II. | Pharmacy |
Rights and ethics for pharmacists | Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language | I. + II. | Pharmacy |
Law and ethics for pharmacists | Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language | I. + II. | Pharmacy |
Pharmaceutical economics and management for pharmacists | Pharmacy – full-time study, Slovak language | I. + II. | Pharmacy |
Law and ethics for pharmacists | Pharmacy – full-time study, Slovak language | I. + II. | Pharmacy |
VI. Overview of research/artistic/other outputs
The last six completed calendar years: 2020–2025. The current year is excluded.
VI.1. Overview of research/artistic/other outputs and citations
| Total | Over the last six years | |
|---|---|---|
| VI.1.1 Number of research/artistic/other outputs | 28 | 7 |
| VI.1.2 Number of outputs registered in Web of Science or Scopus | 4 | 3 |
| VI.1.3 Number of citations corresponding to research/artistic/other outputs | 16 | 13 |
| VI.1.4 Number of citations registered in Web of Science or Scopus | 16 | 13 |
| VI.1.5 Number of invited lectures at international and national level | 0 | 0 |
VI.2. The most significant research/artistic/other outputs
| 1. | ÁGH, Tamás - INOTAI, András - SZILBERHORN, László - CULIG, Josip - VIŠŇANSKÝ, Martin - KALÓ, Zoltán - PETROVA, Guenka. A Novel Method for Calculating Medication Adherence to Poly-Pharmacotherapy by Linking General Practice Prescribing Data and Pharmacy Dispensing Records. In: ISPOR : Congress. Value In Health. 2015. ISSN 1098-3015, Vol. 18, č. 7(2015), s. A737. (2015: 3.824 - IF, 97 - H-index, 3.761 - IF 5y, 1.736 - SJR, Q1 - SJR Best Q, Q1 - JCR Best Q, 1.352 - ABDC). |
|---|---|
| 2. | BUŠÁNYOVÁ, Beáta - VAJTER, Marie - KELIFOVÁ, Silvie - LIŠKOVÁ, Petra - MIKOVÁ, Hedviga - BRECIKOVÁ, Katarína - ŽIGMOND, Ján - ROGALEWICZ, Vladimír - TICHOPÁD, Aleš - VIŠŇANSKÝ, Martin - ŠARKANOVÁ, Ivana. Leber hereditary optic neuropathy in Czechia and Slovakia: Quality of life and costs from patient perspective. In: Heliyon. 2024. ISSN 2405-8440, Vol. 10, no. 11 (2024), art. no. e32296, p. [1-8]. (2024: 3.4 - IF, 3.9 - IF 5y, 0.627 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q, 0.613 - ABDC). |
| 3. | HAWLINA, Marko - KOVAČ, Lea - BRECIKOVÁ, Katarína - ŽIGMOND, Ján - ROGALEWICZ, Vladimír - TICHOPÁD, Aleš - VIŠŇANSKÝ, Martin - ŠARKANOVÁ, Ivana. Leber hereditary optic neuropathy in Slovenia: quality of life and costs from patient perspective. In: Orphanet journal of rare diseases. 2024. ISSN 1750-1172, Vol. 19, no. 1 (2024), art. no. 318, p. [1-6]. (2024: 3.5 - IF, 4 - IF 5y, 1.269 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q, 1.28 - ABDC). |
| 4. | BUCEK PŠENKOVÁ, Mária - HLAVINKOVÁ, Lucia - VIŠŇANSKÝ, Martin - GREGA, Dominik - ONDRUŠOVÁ, Martina. The checklist for standard methodological requirements and reporting of economic evaluation of medicines in Slovakia. In: Value in Health Regional Issues. 2024. ISSN 2212-1099, Vol. 39, no. (2024), p. 14-19. (2024: 1.5 - IF, 1.7 - IF 5y, 0.626 - SJR, Q1 - SJR Best Q, Q3 - JCR Best Q, 0.507 - ABDC). |
| 5. | GREGA, Dominik - KOLÁŘ, Jozef - VIŠŇANSKÝ, Martin. Average CET limit: Is it possible to introduce a single CET for the whole EEA? In: ISPOR Europe. Value In Health. 2022. ISSN 1098-3015, Vol. 25, no. 12, suppl. (2022), p. 557. (2022: 4.5 - IF, 124 - H-index, 6.2 - IF 5y, 1.414 - SJR, Q1 - SJR Best Q, Q1 - JCR Best Q, 2.094 - ABDC). |
VI.3. The most significant research/artistic/other outputs over the last six years
| 1. | BUŠÁNYOVÁ, Beáta - VAJTER, Marie - KELIFOVÁ, Silvie - LIŠKOVÁ, Petra - MIKOVÁ, Hedviga - BRECIKOVÁ, Katarína - ŽIGMOND, Ján - ROGALEWICZ, Vladimír - TICHOPÁD, Aleš - VIŠŇANSKÝ, Martin - ŠARKANOVÁ, Ivana. Leber hereditary optic neuropathy in Czechia and Slovakia: Quality of life and costs from patient perspective. In: Heliyon. 2024. ISSN 2405-8440, Vol. 10, no. 11 (2024), art. no. e32296, p. [1-8]. (2024: 3.4 - IF, 3.9 - IF 5y, 0.627 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q, 0.613 - ABDC). |
|---|---|
| 2. | HAWLINA, Marko - KOVAČ, Lea - BRECIKOVÁ, Katarína - ŽIGMOND, Ján - ROGALEWICZ, Vladimír - TICHOPÁD, Aleš - VIŠŇANSKÝ, Martin - ŠARKANOVÁ, Ivana. Leber hereditary optic neuropathy in Slovenia: quality of life and costs from patient perspective. In: Orphanet journal of rare diseases. 2024. ISSN 1750-1172, Vol. 19, no. 1 (2024), art. no. 318, p. [1-6]. (2024: 3.5 - IF, 4 - IF 5y, 1.269 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q, 1.28 - ABDC). |
| 3. | BUCEK PŠENKOVÁ, Mária - HLAVINKOVÁ, Lucia - VIŠŇANSKÝ, Martin - GREGA, Dominik - ONDRUŠOVÁ, Martina. The checklist for standard methodological requirements and reporting of economic evaluation of medicines in Slovakia. In: Value in Health Regional Issues. 2024. ISSN 2212-1099, Vol. 39, no. (2024), p. 14-19. (2024: 1.5 - IF, 1.7 - IF 5y, 0.626 - SJR, Q1 - SJR Best Q, Q3 - JCR Best Q, 0.507 - ABDC). |
| 4. | GREGA, Dominik - KOLÁŘ, Jozef - VIŠŇANSKÝ, Martin. Average CET limit: Is it possible to introduce a single CET for the whole EEA? In: ISPOR Europe. Value In Health. 2022. ISSN 1098-3015, Vol. 25, no. 12, suppl. (2022), p. 557. (2022: 4.5 - IF, 124 - H-index, 6.2 - IF 5y, 1.414 - SJR, Q1 - SJR Best Q, Q1 - JCR Best Q, 2.094 - ABDC). |
| 5. | VIŠŇANSKÝ, Martin. Financovanie inovatívnych medicínskych technológií [Financing the innovative health technologies]. In: Škola - Veda - Prax, 17.-18. september 2019, Košice : Zborník referátov a abstraktov: vedecká konferencia pri príležitosti 70. výročia založenia UVLF v Košiciach. 1. vyd. Košice : UVLF, 2019. ISBN 978-80-8077-628-2, CD-ROM, s. 158-160. |
VI.4. The most significant citations corresponding to research/artistic/other outputs
| 1. | BUCEK PŠENKOVÁ, Mária - VIŠŇANSKÝ, Martin - MACKOVIČOVÁ, Stanislava - TOMEK, Dominik. The Drug Policy in Central European Countries - Slovakia [Lieková politika v strednej a východnej Európe - Slovensko]. In: Value in Health Regional Issues. 2017. ISSN 2212-1099, Vol. 13(2017), s. 44-49. (15 - H-index, 0.366 - SJR, Q2 - SJR Best Q). [1] CRACIUN, Petru - PANA, Marian - LUPULIASA, Dumitru - CRACIUN, Maria-Dorina - TAEREL, Adriana-Elena. PRESCRIPTION DRUG (RX) EVOLUTION IN ROMANIA BETWEEN 2010 AND 2020. In FARMACIA. ISSN 0014-8237, 2021, vol. 69, no. 5, pp. 980-987. Dostupné na: https://doi.org/10.31925/farmacia.2021.5.23. |
|---|---|
| 2. | BUCEK PŠENKOVÁ, Mária - VIŠŇANSKÝ, Martin - MACKOVIČOVÁ, Stanislava - TOMEK, Dominik. The Drug Policy in Central European Countries - Slovakia [Lieková politika v strednej a východnej Európe - Slovensko]. In: Value in Health Regional Issues. 2017. ISSN 2212-1099, Vol. 13(2017), s. 44-49. (15 - H-index, 0.366 - SJR, Q2 - SJR Best Q). [1] DOLLIVER, Diana S. A supply-based response to a demand-driven problem: a fifteen-year analysis of drug interdiction in Poland. In Crime, Law and Social Change. ISSN 09254994, 2020-01-01, 73, 1, pp. |
| 3. | BUCEK PŠENKOVÁ, Mária - VIŠŇANSKÝ, Martin - MACKOVIČOVÁ, Stanislava - TOMEK, Dominik. The Drug Policy in Central European Countries - Slovakia [Lieková politika v strednej a východnej Európe - Slovensko]. In: Value in Health Regional Issues. 2017. ISSN 2212-1099, Vol. 13(2017), s. 44-49. (15 - H-index, 0.366 - SJR, Q2 - SJR Best Q). [1] TESAR, Tomas - OBSITNIK, Branislav - KALÓ, Zoltán - KRISTENSEN, Finn Børlum. How changes in reimbursement practices influence the financial sustainability of medicine policy: Lessons learned from Slovakia. In Frontiers in Pharmacology, 2019-01-01, 10, jUN, pp. |
| 4. | BUCEK PŠENKOVÁ, Mária - VIŠŇANSKÝ, Martin - MACKOVIČOVÁ, Stanislava - TOMEK, Dominik. The Drug Policy in Central European Countries - Slovakia [Lieková politika v strednej a východnej Európe - Slovensko]. In: Value in Health Regional Issues. 2017. ISSN 2212-1099, Vol. 13(2017), s. 44-49. (15 - H-index, 0.366 - SJR, Q2 - SJR Best Q). [1] YFANTOPOULOS, John N. - CHANTZARAS, Athanasios. Drug Policy in Greece. In Value in Health Regional Issues. ISSN 22121099, 2018-09-01, 16, pp. 66-73. |
VI.5. Participation in conducting or leading the most important projects over the last six years
No records yet.
VII. Overview of organizational experience related to higher education and research/artistic/other activities
| Position / activity | Institution | Year |
|---|---|---|
Chairman | CEE Consortium, ISPOR | 2019 – 2021 |
Chairman | Slovak Pharmacoeconomic Society, member of SMS | 2017 – 2025 |
VIII. Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study
No records yet.
IX. Other relevant facts
No records yet.